000			05420nam a2200469 i 4500
999			_c10334 _d10334
001			10334
003			ES-MaUEC
005			20210608040358.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			180130s2018 gw | fo |||| 0|eng d
020			_a9783319635408
024	7		_a10.1007/978-3-319-63540-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
041	0		_aeng
050		4	_aRG186 .M46 _b2018 EB
245	0	0	_aPre-Menopause, Menopause and Beyond : _bVolume 5: Frontiers in Gynecological Endocrinology _cedited by Martin Birkhaeuser, Andrea R. Genazzani
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2018
300			_a1 recurso en línea (IX, 327 páginas) _b33 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	1		_aISGE Series, _x2197-8735
490	0		_aMedicine (Springer-11650)
505	0		_aPart I Menopause: symptoms and neuroendocrine impact Intracrinology made menopause possible -- From menopause to aging: endocrine and neuroendocrine biological changes -- Brain impact of sex steroids withdrawall of the menopause -- Climacteric symptoms: importance and management -- Part II Fertility 2016 IMS Recommendations on women’s midlife health, “POI” and menopause hormone therapy (MHT) -- Female infertility and autoimmunity -- Is IVF/ICSI/ET reasonable beyond the female age of 40 years? -- IVF: new developments in patient tailored ovarian stimulation -- Oocyte donation in peri-menopausal and menopausal women -- Part III Thyroid disorders, polycystic ovary and metabolic syndrome Thyroid disorders in climacteric women -- Thyroid function and pregnancy outcome after ART: what is the evidence? -- PCOS: implications of cardio-metabolic dysfunction -- Why Metformin is so important for prevention and treatment in climacteric women? -- Metabolic changes during menopausal trans ition -- Weight and body composition management after menopause -- Part IV Bone and cardiovascular impact Healthy bones after menopause – what has to be done? -- The effect of menopause and HRT on coronary heart disease -- How to prevent cardiovascular disorders: influence of gonadal steroids on the heart -- Part V Benign breast diseases, BRCA mutation and breast cancer Risk reducing surgery and treatment of menopausal symptoms in BRCA mutation carriers (and other high risk women) -- Benign breast disease during women’s life -- Treatment of menopausal symptoms in breast cancer survivors -- Myo-inositol and Inositol Hexaphosphate (IP6) in the treatment of breast cancer -- Part VI Menopause symptoms: the therapies The true risks of hormone replacement therapy -- Menopausal hormone therapy customization -- Vulvovaginal atrophy (VVA) and Genitourinary Syndrome of Menopause (GSM): Advances in management -- Menopause symptoms: new treatment options -- Intravaginal DHEA for the treatment of vaginal atrophy closest to physiology -- Part VII Surgical challenges after menopause: problems and solutions Bladder dysfunction and urinary incontinence after the menopause: hormones, drugs or surgery? -- When is ovarectomy and when tubectomy indicated at necessary hysterectomies beyond the reproductive age? -- Pelvic floor reconstructive surgery in ageing women: tailoring the treatment to each woman’s needs.
520	3		_aThis volume represents an up-to-date overview on pre-Menopause and Menopause, with their respective clinical implications and therapies. The aim is to clarify possible doubts and clinical approaches to this particular period in a woman’s life and how to face it, both offering solutions to actual problems and focusing on the potential impact of preventive medicine in improving women’s health and quality of life. The volume is published within the International Society of Gynecological Endocrinology (ISGE) Series, and is based on the 2017 International School of Gynecological and Reproductive Endocrinology Winter Course. This book, covering a very wide range of topics with particular focus on fertility in pre- and peri-menopausal women, climacteric and menopausal symptoms, impact of PCOS on post-menopausal health, breast disease, surgical treatments and therapies, will be an invaluable tool for gynecologists, endocrinologists, and experts in women’s health. .
988			_aEBSPRINGER_2018
650		7	_2embne _9138616 _aMenopausia
650		7	_2embne _9158369 _aPerimenopausia
650		7	_2embne _aEndocrinología ginecológica _9145924
700	1		_aBirkhaeuser, Martin. _eeditor literario
700	1		_aGenazzani, Andrea R. _eeditor literario _0http://id.loc.gov/authorities/names/n80092260 _0http://viaf.org/viaf/19845281 _988509
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996
776	0	8	_iEdición impresa: _z9783319635392
776	0	8	_iEdición impresa: _z9783319635415
776	0	8	_iEdición impresa: _z9783319875828
830		0	_aISGE Series, _x2197-8735 _0http://id.loc.gov/authorities/names/no2014052357
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-63540-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE _n0
998			_db _zSI